nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—NME1—peripheral nervous system neoplasm	0.438	0.931	CbGaD
Lamivudine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.0658	0.182	CbGbCtD
Lamivudine—ABCB1—peripheral nervous system neoplasm	0.0322	0.0686	CbGaD
Lamivudine—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0207	0.0572	CbGbCtD
Lamivudine—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0206	0.0571	CbGbCtD
Lamivudine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0199	0.0551	CbGbCtD
Lamivudine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0195	0.0538	CbGbCtD
Lamivudine—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0193	0.0534	CbGbCtD
Lamivudine—ABCC3—Etoposide—peripheral nervous system neoplasm	0.019	0.0524	CbGbCtD
Lamivudine—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0149	0.0413	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0138	0.0382	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0129	0.0358	CbGbCtD
Lamivudine—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0127	0.0351	CbGbCtD
Lamivudine—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0116	0.0322	CbGbCtD
Lamivudine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0107	0.0297	CbGbCtD
Lamivudine—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00941	0.026	CbGbCtD
Lamivudine—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00877	0.0243	CbGbCtD
Lamivudine—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00862	0.0238	CbGbCtD
Lamivudine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00851	0.0235	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00794	0.022	CbGbCtD
Lamivudine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00793	0.0219	CbGbCtD
Lamivudine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00779	0.0215	CbGbCtD
Lamivudine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00719	0.0199	CbGbCtD
Lamivudine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00719	0.0199	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00588	0.0163	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00532	0.0147	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00498	0.0138	CbGbCtD
Lamivudine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00307	0.00848	CbGbCtD
Lamivudine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00286	0.00791	CbGbCtD
Lamivudine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00281	0.00777	CbGbCtD
Lamivudine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.0053	CbGbCtD
Lamivudine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000422	0.519	CbGdCrCtD
Lamivudine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.481	CbGdCrCtD
Lamivudine—PGK1—brainstem—peripheral nervous system neoplasm	0.000242	0.145	CbGeAlD
Lamivudine—CMPK1—brainstem—peripheral nervous system neoplasm	0.000124	0.0741	CbGeAlD
Lamivudine—NME2—brainstem—peripheral nervous system neoplasm	0.000121	0.0724	CbGeAlD
Lamivudine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.000121	0.0724	CbGeAlD
Lamivudine—PGK1—cerebellum—peripheral nervous system neoplasm	0.000119	0.0715	CbGeAlD
Lamivudine—SLC22A3—tongue—peripheral nervous system neoplasm	0.000114	0.0684	CbGeAlD
Lamivudine—NT5C—cerebellum—peripheral nervous system neoplasm	0.000101	0.0604	CbGeAlD
Lamivudine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	8.4e-05	0.0503	CbGeAlD
Lamivudine—DCK—trigeminal ganglion—peripheral nervous system neoplasm	6.96e-05	0.0417	CbGeAlD
Lamivudine—DCK—parotid gland—peripheral nervous system neoplasm	6.56e-05	0.0393	CbGeAlD
Lamivudine—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	6.47e-05	0.0011	CbGpPWpGaD
Lamivudine—NME1—cerebellum—peripheral nervous system neoplasm	6.32e-05	0.0379	CbGeAlD
Lamivudine—NME1—Metabolism—GNS—peripheral nervous system neoplasm	6.29e-05	0.00107	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—HGF—peripheral nervous system neoplasm	6.25e-05	0.00107	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—BCHE—peripheral nervous system neoplasm	6.13e-05	0.00105	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—BCHE—peripheral nervous system neoplasm	6.13e-05	0.00105	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—BCHE—peripheral nervous system neoplasm	6.13e-05	0.00105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.1e-05	0.00104	CbGpPWpGaD
Lamivudine—CMPK1—cerebellum—peripheral nervous system neoplasm	6.09e-05	0.0365	CbGeAlD
Lamivudine—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.97e-05	0.00102	CbGpPWpGaD
Lamivudine—NME2—cerebellum—peripheral nervous system neoplasm	5.96e-05	0.0357	CbGeAlD
Lamivudine—PGK1—Metabolism—ENO2—peripheral nervous system neoplasm	5.92e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	5.88e-05	0.001	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.85e-05	0.000998	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.85e-05	0.000998	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.85e-05	0.000998	CbGpPWpGaD
Lamivudine—NME1—Metabolism—COX2—peripheral nervous system neoplasm	5.81e-05	0.00099	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—TH—peripheral nervous system neoplasm	5.77e-05	0.000983	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—TH—peripheral nervous system neoplasm	5.77e-05	0.000983	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TH—peripheral nervous system neoplasm	5.77e-05	0.000983	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	5.74e-05	0.000978	CbGpPWpGaD
Lamivudine—PGK1—Disease—SLC2A1—peripheral nervous system neoplasm	5.7e-05	0.000971	CbGpPWpGaD
Lamivudine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	5.67e-05	0.034	CbGeAlD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	5.59e-05	0.000954	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.58e-05	0.000952	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ENO2—peripheral nervous system neoplasm	5.5e-05	0.000938	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	5.47e-05	0.000932	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.37e-05	0.000916	CbGpPWpGaD
Lamivudine—SLC22A3—parotid gland—peripheral nervous system neoplasm	5.35e-05	0.032	CbGeAlD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.18e-05	0.000882	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.13e-05	0.000875	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	5.07e-05	0.000864	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ENO2—peripheral nervous system neoplasm	5.03e-05	0.000858	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—BCHE—peripheral nervous system neoplasm	5e-05	0.000852	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	4.96e-05	0.000845	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.94e-05	0.000842	CbGpPWpGaD
Lamivudine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	4.94e-05	0.00046	CcSEcCtD
Lamivudine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	4.94e-05	0.00046	CcSEcCtD
Lamivudine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000459	CcSEcCtD
Lamivudine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	4.92e-05	0.000459	CcSEcCtD
Lamivudine—Skin disorder—Etoposide—peripheral nervous system neoplasm	4.91e-05	0.000458	CcSEcCtD
Lamivudine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	4.89e-05	0.000456	CcSEcCtD
Lamivudine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000455	CcSEcCtD
Lamivudine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.000454	CcSEcCtD
Lamivudine—Anorexia—Etoposide—peripheral nervous system neoplasm	4.82e-05	0.000449	CcSEcCtD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.82e-05	0.000821	CbGpPWpGaD
Lamivudine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000448	CcSEcCtD
Lamivudine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	4.8e-05	0.000447	CcSEcCtD
Lamivudine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000447	CcSEcCtD
Lamivudine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	4.78e-05	0.000446	CcSEcCtD
Lamivudine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	4.77e-05	0.000445	CcSEcCtD
Lamivudine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000445	CcSEcCtD
Lamivudine—PGK1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.77e-05	0.000813	CbGpPWpGaD
Lamivudine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	4.77e-05	0.000444	CcSEcCtD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.75e-05	0.00081	CbGpPWpGaD
Lamivudine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000441	CcSEcCtD
Lamivudine—Hypotension—Etoposide—peripheral nervous system neoplasm	4.73e-05	0.00044	CcSEcCtD
Lamivudine—Pain—Cisplatin—peripheral nervous system neoplasm	4.72e-05	0.00044	CcSEcCtD
Lamivudine—NT5C—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-05	0.000803	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-05	0.000803	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-05	0.000803	CbGpPWpGaD
Lamivudine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000439	CcSEcCtD
Lamivudine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000439	CcSEcCtD
Lamivudine—PGK1—Metabolism—TH—peripheral nervous system neoplasm	4.7e-05	0.000801	CbGpPWpGaD
Lamivudine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000434	CcSEcCtD
Lamivudine—Dysuria—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000434	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—BCHE—peripheral nervous system neoplasm	4.65e-05	0.000792	CbGpPWpGaD
Lamivudine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	4.65e-05	0.000433	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000433	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.64e-05	0.000791	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.62e-05	0.000788	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ABCB1—peripheral nervous system neoplasm	4.62e-05	0.000788	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.62e-05	0.000788	CbGpPWpGaD
Lamivudine—Influenza—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.00043	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.00043	CcSEcCtD
Lamivudine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000429	CcSEcCtD
Lamivudine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	4.6e-05	0.000429	CcSEcCtD
Lamivudine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	4.58e-05	0.000427	CcSEcCtD
Lamivudine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	4.55e-05	0.000424	CcSEcCtD
Lamivudine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.54e-05	0.000423	CcSEcCtD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	4.54e-05	0.000773	CbGpPWpGaD
Lamivudine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000421	CcSEcCtD
Lamivudine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.51e-05	0.00042	CcSEcCtD
Lamivudine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000419	CcSEcCtD
Lamivudine—Somnolence—Etoposide—peripheral nervous system neoplasm	4.5e-05	0.000419	CcSEcCtD
Lamivudine—Asthenia—Vincristine—peripheral nervous system neoplasm	4.48e-05	0.000417	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.44e-05	0.000414	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000413	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.44e-05	0.000756	CbGpPWpGaD
Lamivudine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.43e-05	0.000413	CcSEcCtD
Lamivudine—ABCC1—parotid gland—peripheral nervous system neoplasm	4.42e-05	0.0265	CbGeAlD
Lamivudine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000411	CcSEcCtD
Lamivudine—Rash—Dactinomycin—peripheral nervous system neoplasm	4.41e-05	0.000411	CcSEcCtD
Lamivudine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.4e-05	0.00041	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000408	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—TH—peripheral nervous system neoplasm	4.37e-05	0.000745	CbGpPWpGaD
Lamivudine—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000407	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.37e-05	0.000407	CcSEcCtD
Lamivudine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.36e-05	0.000407	CcSEcCtD
Lamivudine—Fatigue—Etoposide—peripheral nervous system neoplasm	4.36e-05	0.000406	CcSEcCtD
Lamivudine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000406	CcSEcCtD
Lamivudine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000404	CcSEcCtD
Lamivudine—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000404	CcSEcCtD
Lamivudine—Pain—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000403	CcSEcCtD
Lamivudine—Constipation—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000403	CcSEcCtD
Lamivudine—DCK—Metabolism—GNS—peripheral nervous system neoplasm	4.32e-05	0.000736	CbGpPWpGaD
Lamivudine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000402	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000402	CcSEcCtD
Lamivudine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.28e-05	0.000399	CcSEcCtD
Lamivudine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.27e-05	0.000398	CcSEcCtD
Lamivudine—Sweating—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000397	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000397	CcSEcCtD
Lamivudine—NME2—Metabolism—BCHE—peripheral nervous system neoplasm	4.25e-05	0.000725	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.25e-05	0.000725	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	4.23e-05	0.000721	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	4.22e-05	0.000719	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.22e-05	0.000719	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.21e-05	0.000717	CbGpPWpGaD
Lamivudine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000392	CcSEcCtD
Lamivudine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000391	CcSEcCtD
Lamivudine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000389	CcSEcCtD
Lamivudine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.17e-05	0.000388	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000388	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.15e-05	0.000387	CcSEcCtD
Lamivudine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000387	CcSEcCtD
Lamivudine—DCK—Metabolism—NME1—peripheral nervous system neoplasm	4.14e-05	0.000706	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.14e-05	0.000385	CcSEcCtD
Lamivudine—Dizziness—Vincristine—peripheral nervous system neoplasm	4.13e-05	0.000385	CcSEcCtD
Lamivudine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.12e-05	0.000384	CcSEcCtD
Lamivudine—Rash—Alitretinoin—peripheral nervous system neoplasm	4.09e-05	0.000381	CcSEcCtD
Lamivudine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.08e-05	0.00038	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.00038	CcSEcCtD
Lamivudine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.07e-05	0.000379	CcSEcCtD
Lamivudine—Headache—Alitretinoin—peripheral nervous system neoplasm	4.06e-05	0.000378	CcSEcCtD
Lamivudine—NME2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.06e-05	0.000691	CbGpPWpGaD
Lamivudine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000377	CcSEcCtD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.04e-05	0.000689	CbGpPWpGaD
Lamivudine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000376	CcSEcCtD
Lamivudine—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.02e-05	0.000685	CbGpPWpGaD
Lamivudine—Urticaria—Etoposide—peripheral nervous system neoplasm	4.02e-05	0.000374	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000374	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000374	CcSEcCtD
Lamivudine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000373	CcSEcCtD
Lamivudine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4e-05	0.000373	CcSEcCtD
Lamivudine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4e-05	0.000373	CcSEcCtD
Lamivudine—NME2—Metabolism—TH—peripheral nervous system neoplasm	4e-05	0.000681	CbGpPWpGaD
Lamivudine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000372	CcSEcCtD
Lamivudine—DCK—Metabolism—COX2—peripheral nervous system neoplasm	3.98e-05	0.000679	CbGpPWpGaD
Lamivudine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.00037	CcSEcCtD
Lamivudine—Vomiting—Vincristine—peripheral nervous system neoplasm	3.97e-05	0.00037	CcSEcCtD
Lamivudine—Asthenia—Cisplatin—peripheral nervous system neoplasm	3.96e-05	0.000369	CcSEcCtD
Lamivudine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000369	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000367	CcSEcCtD
Lamivudine—Rash—Vincristine—peripheral nervous system neoplasm	3.94e-05	0.000367	CcSEcCtD
Lamivudine—Dermatitis—Vincristine—peripheral nervous system neoplasm	3.93e-05	0.000366	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000365	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.91e-05	0.000667	CbGpPWpGaD
Lamivudine—Headache—Vincristine—peripheral nervous system neoplasm	3.91e-05	0.000364	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000362	CcSEcCtD
Lamivudine—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	3.88e-05	0.0232	CbGeAlD
Lamivudine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000361	CcSEcCtD
Lamivudine—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.87e-05	0.00066	CbGpPWpGaD
Lamivudine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.00036	CcSEcCtD
Lamivudine—Nausea—Alitretinoin—peripheral nervous system neoplasm	3.85e-05	0.000359	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000358	CcSEcCtD
Lamivudine—PGK1—Metabolism—GNAS—peripheral nervous system neoplasm	3.84e-05	0.000654	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ENO2—peripheral nervous system neoplasm	3.81e-05	0.00065	CbGpPWpGaD
Lamivudine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.78e-05	0.000352	CcSEcCtD
Lamivudine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000352	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.77e-05	0.000643	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.77e-05	0.000642	CbGpPWpGaD
Lamivudine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.73e-05	0.000347	CcSEcCtD
Lamivudine—Nausea—Vincristine—peripheral nervous system neoplasm	3.71e-05	0.000346	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000345	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000344	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000342	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000341	CcSEcCtD
Lamivudine—ABCG2—parotid gland—peripheral nervous system neoplasm	3.66e-05	0.0219	CbGeAlD
Lamivudine—Asthenia—Etoposide—peripheral nervous system neoplasm	3.63e-05	0.000338	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000338	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000336	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000335	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.59e-05	0.000612	CbGpPWpGaD
Lamivudine—Chills—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000334	CcSEcCtD
Lamivudine—Pruritus—Etoposide—peripheral nervous system neoplasm	3.58e-05	0.000333	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—GNAS—peripheral nervous system neoplasm	3.57e-05	0.000608	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.54e-05	0.000603	CbGpPWpGaD
Lamivudine—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000329	CcSEcCtD
Lamivudine—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.51e-05	0.000327	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.51e-05	0.000598	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.5e-05	0.000597	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ABCB1—peripheral nervous system neoplasm	3.5e-05	0.000597	CbGpPWpGaD
Lamivudine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000325	CcSEcCtD
Lamivudine—Rash—Cisplatin—peripheral nervous system neoplasm	3.48e-05	0.000324	CcSEcCtD
Lamivudine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.48e-05	0.000324	CcSEcCtD
Lamivudine—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	3.48e-05	0.000593	CbGpPWpGaD
Lamivudine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000324	CcSEcCtD
Lamivudine—Erythema—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000324	CcSEcCtD
Lamivudine—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.47e-05	0.000591	CbGpPWpGaD
Lamivudine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.46e-05	0.000322	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000319	CcSEcCtD
Lamivudine—Tension—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000318	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.4e-05	0.00058	CbGpPWpGaD
Lamivudine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000317	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.37e-05	0.000314	CcSEcCtD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.37e-05	0.000574	CbGpPWpGaD
Lamivudine—Back pain—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000313	CcSEcCtD
Lamivudine—Dizziness—Etoposide—peripheral nervous system neoplasm	3.34e-05	0.000312	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000311	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000311	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.00031	CcSEcCtD
Lamivudine—Chills—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000309	CcSEcCtD
Lamivudine—Nausea—Cisplatin—peripheral nervous system neoplasm	3.28e-05	0.000306	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.27e-05	0.000557	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.26e-05	0.000556	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GNAS—peripheral nervous system neoplasm	3.26e-05	0.000556	CbGpPWpGaD
Lamivudine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000304	CcSEcCtD
Lamivudine—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	3.24e-05	0.000552	CbGpPWpGaD
Lamivudine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.0003	CcSEcCtD
Lamivudine—NME1—Metabolism—BCHE—peripheral nervous system neoplasm	3.22e-05	0.000549	CbGpPWpGaD
Lamivudine—Vomiting—Etoposide—peripheral nervous system neoplasm	3.22e-05	0.0003	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000299	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000299	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000299	CcSEcCtD
Lamivudine—NME2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.2e-05	0.000546	CbGpPWpGaD
Lamivudine—Rash—Etoposide—peripheral nervous system neoplasm	3.19e-05	0.000297	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.19e-05	0.000297	CcSEcCtD
Lamivudine—PGK1—Disease—PTPN11—peripheral nervous system neoplasm	3.19e-05	0.000543	CbGpPWpGaD
Lamivudine—Headache—Etoposide—peripheral nervous system neoplasm	3.17e-05	0.000295	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000295	CcSEcCtD
Lamivudine—Tension—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000294	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000293	CcSEcCtD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.14e-05	0.000535	CbGpPWpGaD
Lamivudine—Malaise—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000292	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000291	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000291	CcSEcCtD
Lamivudine—Syncope—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.00029	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.00029	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.00029	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000288	CcSEcCtD
Lamivudine—NME1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.07e-05	0.000524	CbGpPWpGaD
Lamivudine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000284	CcSEcCtD
Lamivudine—DCK—cerebellum—peripheral nervous system neoplasm	3.03e-05	0.0182	CbGeAlD
Lamivudine—Cough—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000282	CcSEcCtD
Lamivudine—NME1—Metabolism—TH—peripheral nervous system neoplasm	3.03e-05	0.000516	CbGpPWpGaD
Lamivudine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.00028	CcSEcCtD
Lamivudine—Nausea—Etoposide—peripheral nervous system neoplasm	3e-05	0.00028	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000278	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000277	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000276	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000276	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000276	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000275	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000274	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000272	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.00027	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.00027	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000269	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000269	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.88e-05	0.000491	CbGpPWpGaD
Lamivudine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000268	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000266	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.84e-05	0.000485	CbGpPWpGaD
Lamivudine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000264	CcSEcCtD
Lamivudine—Oedema—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000264	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000263	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.82e-05	0.00048	CbGpPWpGaD
Lamivudine—Infection—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000262	CcSEcCtD
Lamivudine—Cough—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000261	CcSEcCtD
Lamivudine—Shock—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.00026	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000259	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000259	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000259	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000257	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.000255	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000255	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000255	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000255	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000254	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—GNS—peripheral nervous system neoplasm	2.73e-05	0.000465	CbGpPWpGaD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000253	CcSEcCtD
Lamivudine—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.72e-05	0.000463	CbGpPWpGaD
Lamivudine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000252	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.000252	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000249	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000247	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000246	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.000244	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.000244	CcSEcCtD
Lamivudine—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	2.62e-05	0.000446	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NME1—peripheral nervous system neoplasm	2.61e-05	0.000446	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.61e-05	0.000445	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	2.61e-05	0.000445	CbGpPWpGaD
Lamivudine—Infection—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000243	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000241	CcSEcCtD
Lamivudine—Shock—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.00024	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.00024	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.000239	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.000239	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000237	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000237	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000236	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000236	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.52e-05	0.000235	CcSEcCtD
Lamivudine—PGK1—Disease—ERBB2—peripheral nervous system neoplasm	2.52e-05	0.000429	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—COX2—peripheral nervous system neoplasm	2.52e-05	0.000429	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	2.51e-05	0.000428	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	2.51e-05	0.000427	CbGpPWpGaD
Lamivudine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000233	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000233	CcSEcCtD
Lamivudine—NME1—Metabolism—GNAS—peripheral nervous system neoplasm	2.47e-05	0.000422	CbGpPWpGaD
Lamivudine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.46e-05	0.00023	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.46e-05	0.000419	CbGpPWpGaD
Lamivudine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000228	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.45e-05	0.000228	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.44e-05	0.000228	CcSEcCtD
Lamivudine—NME1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.43e-05	0.000414	CbGpPWpGaD
Lamivudine—Constipation—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000226	CcSEcCtD
Lamivudine—Pain—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000226	CcSEcCtD
Lamivudine—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	2.4e-05	0.00041	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000223	CcSEcCtD
Lamivudine—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.39e-05	0.000407	CbGpPWpGaD
Lamivudine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.37e-05	0.000221	CcSEcCtD
Lamivudine—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.37e-05	0.000403	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.36e-05	0.000402	CbGpPWpGaD
Lamivudine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000219	CcSEcCtD
Lamivudine—ABCC1—Disease—GNS—peripheral nervous system neoplasm	2.34e-05	0.0004	CbGpPWpGaD
Lamivudine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000218	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.34e-05	0.000218	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	0.000217	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000216	CcSEcCtD
Lamivudine—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	2.31e-05	0.000394	CbGpPWpGaD
Lamivudine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000215	CcSEcCtD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.31e-05	0.000393	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.29e-05	0.00039	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	2.28e-05	0.000389	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.28e-05	0.000389	CbGpPWpGaD
Lamivudine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	0.000212	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.26e-05	0.000211	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.26e-05	0.000211	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.26e-05	0.000385	CbGpPWpGaD
Lamivudine—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.00021	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.24e-05	0.000383	CbGpPWpGaD
Lamivudine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000209	CcSEcCtD
Lamivudine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000209	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000209	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000209	CcSEcCtD
Lamivudine—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	2.21e-05	0.000377	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.2e-05	0.000376	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	2.18e-05	0.000371	CbGpPWpGaD
Lamivudine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	0.000201	CcSEcCtD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.15e-05	0.000367	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	0.0002	CcSEcCtD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.14e-05	0.000365	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.11e-05	0.000359	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.1e-05	0.000358	CbGpPWpGaD
Lamivudine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.09e-05	0.000195	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000194	CcSEcCtD
Lamivudine—DCK—Metabolism—TH—peripheral nervous system neoplasm	2.08e-05	0.000354	CbGpPWpGaD
Lamivudine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000193	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000193	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.000353	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.06e-05	0.000352	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.05e-05	0.000349	CbGpPWpGaD
Lamivudine—ABCC1—cerebellum—peripheral nervous system neoplasm	2.04e-05	0.0123	CbGeAlD
Lamivudine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.03e-05	0.00019	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.000187	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.99e-05	0.00034	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.98e-05	0.000337	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.97e-05	0.000336	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	1.96e-05	0.000335	CbGpPWpGaD
Lamivudine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.94e-05	0.000181	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000331	CbGpPWpGaD
Lamivudine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.00018	CcSEcCtD
Lamivudine—PGK1—Disease—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000326	CbGpPWpGaD
Lamivudine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	1.91e-05	0.0115	CbGeAlD
Lamivudine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.91e-05	0.000326	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	1.88e-05	0.000321	CbGpPWpGaD
Lamivudine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.000175	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000175	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	0.000173	CcSEcCtD
Lamivudine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.84e-05	0.000314	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	1.81e-05	0.000309	CbGpPWpGaD
Lamivudine—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.000168	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.8e-05	0.000307	CbGpPWpGaD
Lamivudine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.79e-05	0.000167	CcSEcCtD
Lamivudine—Rash—Epirubicin—peripheral nervous system neoplasm	1.79e-05	0.000167	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.79e-05	0.000166	CcSEcCtD
Lamivudine—PGK1—Disease—MYC—peripheral nervous system neoplasm	1.78e-05	0.000304	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.78e-05	0.000304	CbGpPWpGaD
Lamivudine—Headache—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000165	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000162	CcSEcCtD
Lamivudine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.73e-05	0.000295	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000293	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	1.71e-05	0.000291	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000289	CbGpPWpGaD
Lamivudine—ABCG2—cerebellum—peripheral nervous system neoplasm	1.69e-05	0.0101	CbGeAlD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000288	CbGpPWpGaD
Lamivudine—Nausea—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000157	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000155	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000284	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	1.66e-05	0.000284	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.66e-05	0.000283	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.66e-05	0.000282	CbGpPWpGaD
Lamivudine—Rash—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000154	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000154	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—ENO2—peripheral nervous system neoplasm	1.65e-05	0.000282	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000281	CbGpPWpGaD
Lamivudine—Headache—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000153	CcSEcCtD
Lamivudine—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.64e-05	0.00028	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	1.64e-05	0.000279	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.000279	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.62e-05	0.000276	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.59e-05	0.000272	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	1.59e-05	0.000272	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.59e-05	0.00027	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	1.58e-05	0.000269	CbGpPWpGaD
Lamivudine—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.56e-05	0.000145	CcSEcCtD
Lamivudine—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	1.53e-05	0.00026	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	1.52e-05	0.000259	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	1.47e-05	0.000251	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000247	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000245	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.42e-05	0.000242	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000242	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.41e-05	0.00024	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000239	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-05	0.000238	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.34e-05	0.000228	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.33e-05	0.000227	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	1.31e-05	0.000224	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000224	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.29e-05	0.00022	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.28e-05	0.000219	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000217	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000217	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000217	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000212	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000211	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.000209	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.21e-05	0.000206	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000204	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.19e-05	0.000203	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000195	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000185	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000183	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000181	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.05e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.05e-05	0.000178	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000177	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.04e-05	0.000177	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	0.000171	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	9.92e-06	0.000169	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	9.85e-06	0.000168	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.84e-06	0.000168	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.74e-06	0.000166	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	9.66e-06	0.000165	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	9.66e-06	0.000165	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—peripheral nervous system neoplasm	9.63e-06	0.000164	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.59e-06	0.000163	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	9.54e-06	0.000163	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	9.45e-06	0.000161	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	9.34e-06	0.000159	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	8.96e-06	0.000153	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	8.85e-06	0.000151	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—peripheral nervous system neoplasm	8.81e-06	0.00015	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.75e-06	0.000149	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	8.62e-06	0.000147	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.44e-06	0.000144	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.35e-06	0.000142	CbGpPWpGaD
Lamivudine—ABCB1—cerebellum—peripheral nervous system neoplasm	8.35e-06	0.005	CbGeAlD
Lamivudine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	8.32e-06	0.000142	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	8.23e-06	0.00014	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	8.16e-06	0.000139	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	8.16e-06	0.000139	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.84e-06	0.000134	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.78e-06	0.000133	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	7.72e-06	0.000132	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.68e-06	0.000131	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	7.67e-06	0.000131	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	7.6e-06	0.00013	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.57e-06	0.000129	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	7.3e-06	0.000124	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	6.98e-06	0.000119	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	6.79e-06	0.000116	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.72e-06	0.000115	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—peripheral nervous system neoplasm	6.68e-06	0.000114	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.66e-06	0.000114	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.59e-06	0.000112	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	6.4e-06	0.000109	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.31e-06	0.000108	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.26e-06	0.000107	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	6.16e-06	0.000105	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.15e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.66e-06	9.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.33e-06	9.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	5.06e-06	8.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.78e-06	8.15e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	4.58e-06	7.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.56e-06	7.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.5e-06	7.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	3.85e-06	6.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.67e-06	6.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—peripheral nervous system neoplasm	3.59e-06	6.11e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	2.89e-06	4.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	2.82e-06	4.8e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	2.66e-06	4.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	2.49e-06	4.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.08e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.83e-06	3.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.81e-06	3.09e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.69e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	9.91e-07	1.69e-05	CbGpPWpGaD
